Skip to Content
Are you living with NSCLC? Learn your prognosis here >>

umeclidinium and vilanterol (Inhalation route)

ue-mek-li-DIN-ee-um BROE-mide, vye-LAN-ter-ol trye-FEN-a-tate

Inhalation route(Powder)

Asthma-related death: Long-acting beta(2)-adrenergic agonists (LABA) increase the risk of asthma-related death. Data from a large placebo-controlled US trial that compared the safety of another LABA (salmeterol) with placebo added to the usual asthma therapy showed an increase in asthma-related deaths in subjects receiving salmeterol. This finding with salmeterol is considered a class effect of all LABA, including vilanterol, one of the active ingredients in the umeclidinium/vilanterol combination. The safety and efficacy of umeclidinium/vilanterol in patients with asthma have not been established. Umeclidinium/vilanterol is not indicated for the treatment of asthma .

Commonly used brand name(s)

In the U.S.

  • Anoro Ellipta

Available Dosage Forms:

  • Powder

Therapeutic Class: Respiratory Agent

Pharmacologic Class: Umeclidinium

Uses For umeclidinium and vilanterol

Umeclidinium and vilanterol combination is used to treat air flow blockage in chronic obstructive pulmonary disease (COPD). This includes chronic bronchitis and emphysema.

Umeclidinium and vilanterol combination should not be used for acute breathing problems or in patients with asthma.

Inhaled umeclidinium is an anticholinergic. Inhaled vilanterol is a long-acting bronchodilator. Bronchodilators are medicines that are breathed in through the mouth to open up the bronchial tubes (air passages) in the lungs.

umeclidinium and vilanterol is available only with your doctor's prescription.

Before Using umeclidinium and vilanterol

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For umeclidinium and vilanterol, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to umeclidinium and vilanterol or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Use of umeclidinium and vilanterol combination is not recommended in children. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of umeclidinium and vilanterol combination in the elderly.

Pregnancy

Pregnancy Category Explanation
All Trimesters C Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking umeclidinium and vilanterol, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using umeclidinium and vilanterol with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

  • Amifampridine
  • Amisulpride
  • Bepridil
  • Cisapride
  • Dronedarone
  • Fluconazole
  • Ketoconazole
  • Mesoridazine
  • Nelfinavir
  • Pimozide
  • Piperaquine
  • Posaconazole
  • Saquinavir
  • Sparfloxacin
  • Terfenadine
  • Thioridazine
  • Ziprasidone

Using umeclidinium and vilanterol with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

  • Amineptine
  • Amiodarone
  • Amitriptyline
  • Amitriptylinoxide
  • Amoxapine
  • Anagrelide
  • Aripiprazole
  • Atazanavir
  • Boceprevir
  • Bupropion
  • Buserelin
  • Butriptyline
  • Ceritinib
  • Clarithromycin
  • Clomipramine
  • Cobicistat
  • Conivaptan
  • Crizotinib
  • Dabrafenib
  • Degarelix
  • Delamanid
  • Desipramine
  • Deslorelin
  • Dibenzepin
  • Donepezil
  • Dothiepin
  • Doxepin
  • Efavirenz
  • Escitalopram
  • Gonadorelin
  • Goserelin
  • Histrelin
  • Hydroxychloroquine
  • Hydroxyzine
  • Idelalisib
  • Imipramine
  • Indinavir
  • Iprindole
  • Itraconazole
  • Ivabradine
  • Leuprolide
  • Levofloxacin
  • Lofepramine
  • Lopinavir
  • Melitracen
  • Metronidazole
  • Nafarelin
  • Nefazodone
  • Nilotinib
  • Nortriptyline
  • Opipramol
  • Oxymorphone
  • Panobinostat
  • Pasireotide
  • Pimavanserin
  • Pitolisant
  • Propizepine
  • Protriptyline
  • Quetiapine
  • Ritonavir
  • Sotalol
  • Sulpiride
  • Tacrolimus
  • Telaprevir
  • Telithromycin
  • Tianeptine
  • Tiotropium
  • Tipranavir
  • Trimipramine
  • Triptorelin
  • Troleandomycin
  • Vemurafenib
  • Vinflunine
  • Voriconazole
  • Zuclopenthixol

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using umeclidinium and vilanterol with any of the following is usually not recommended, but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use umeclidinium and vilanterol, or give you special instructions about the use of food, alcohol, or tobacco.

  • Grapefruit Juice

Other Medical Problems

The presence of other medical problems may affect the use of umeclidinium and vilanterol. Make sure you tell your doctor if you have any other medical problems, especially:

  • Allergy to milk proteins—Should not be used in patients with these conditions.
  • Bladder blockage or
  • Diabetes or
  • Enlarged prostate (BPH, prostatic hyperplasia) or
  • Heart or blood vessel disease or
  • Heart rhythm problems (eg, arrhythmia, prolonged QT interval) or
  • Hypertension (high blood pressure) or
  • Hyperthyroidism (overactive thyroid) or
  • Hypokalemia (low potassium in the blood) or
  • Ketoacidosis (high ketones in the blood) or
  • Narrow-angle glaucoma or
  • Problems passing urine or
  • Seizures—Use with caution. May make these conditions worse.

Proper Use of umeclidinium and vilanterol

Use umeclidinium and vilanterol only as directed by your doctor. Do not use more of it and do not use it more often than your doctor ordered. Also, do not stop using umeclidinium and vilanterol without telling your doctor. To do so may increase the chance of side effects.

Inhaled umeclidinium and vilanterol combination comes with patient directions or a Medication Guide. Read the directions carefully before using umeclidinium and vilanterol. If you do not understand the directions or you are not sure how to use the inhaler, ask your doctor to show you what to do. Also, ask your doctor to check regularly how you use the inhaler to make sure you are using it properly.

Use umeclidinium and vilanterol at the same time each day.

Do not stop using umeclidinium and vilanterol or other breathing medicines that your doctor has prescribed for you unless you have discussed this with your doctor.

To use the inhaler:

  • umeclidinium and vilanterol comes in a foil tray. Peel back the lid to open the tray.
  • Slide the inhaler cover down until you hear a clicking sound. The inhaler is now ready to use. Do not open the cover of the inhaler until you are ready to use it. If you open and close the inhaler without inhaling the dose, you will lose the medicine.
  • Turn your head away from the inhaler, and breathe out fully. Do not breathe into the inhaler.
  • Put the mouthpiece between your lips, and close your lips around the mouthpiece. Do not block the air vent with your fingers.
  • Breathe in through your mouth as deeply as you can until you have taken a full deep breath. Do not breathe through your nose.
  • Hold your breath and remove the mouthpiece from your mouth. Continue holding your breath as long as you can up to 3 or 4 seconds before breathing out slowly. This gives the medicine time to settle in your airways and lungs.
  • When you are finished, you may clean the mouthpiece with a dry tissue, if needed, before closing the inhaler cover.
  • The inhaler has a window that shows the number of doses that are left. This tells you when you are getting low on medicine. When the inhaler has less than 10 doses left, the left half of the counter will show up in red to remind you to refill your prescription.

Dosing

The dose of umeclidinium and vilanterol will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of umeclidinium and vilanterol. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

  • For inhalation dosage form (powder):
    • For maintenance treatment of COPD:
      • Adults—One inhalation once a day. Do not take more than one inhalation every 24 hours.
      • Children—Use is not recommended.

Missed Dose

If you miss a dose of umeclidinium and vilanterol, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Keep umeclidinium and vilanterol in a dry place away from heat and sunlight. Throw away umeclidinium and vilanterol 6 weeks after opening or when the counter reads "0".

Precautions While Using umeclidinium and vilanterol

If you will be using umeclidinium and vilanterol for a long time, it is very important that your doctor check your progress at regular visits. This will allow your doctor to see if the medicine is working properly and to check for any unwanted effects.

Tell your doctor if you are also using other medicines for your COPD.

umeclidinium and vilanterol should not be used if you are having a severe COPD attack, or if symptoms of a COPD attack has already started. Your doctor may prescribe another medicine for you to use in case of an acute COPD attack. If the other medicine does not work as well, tell your doctor right away.

Talk with your doctor or get medical care right away if:

  • Your symptoms do not improve after using umeclidinium and vilanterol for 1 week or if they become worse.
  • Your short-acting inhaler does not seem to work as well as it used to and you need it more often than normal (eg, you use 1 whole canister of the short-acting inhaler in 8 weeks time, or you need to use 4 or more inhalations of the short-acting inhaler for 2 or more days in a row).
  • You have a big decrease in your peak flow when measured as directed by your doctor.

umeclidinium and vilanterol should not be used together with similar inhaled medicines such as arformoterol (Brovana®), budesonide/formoterol (Symbicort®), formoterol (Foradil®, Perforomist®), indacaterol (Onbrez®), or salmeterol (Serevent®).

umeclidinium and vilanterol may cause paradoxical bronchospasm, which means your breathing or wheezing will get worse. Paradoxical bronchospasm may be life-threatening. Check with your doctor right away if you have coughing, difficulty breathing, shortness of breath, or wheezing after using umeclidinium and vilanterol.

If you develop a skin rash, hives, or any allergic reaction to umeclidinium and vilanterol, stop using the medicine and check with your doctor as soon as possible.

Check with your doctor right away if blurred vision, difficulty in reading, or any other change in vision occurs during or after treatment. Your doctor may want you to have your eyes checked by an ophthalmologist (eye doctor).

umeclidinium and vilanterol may affect blood sugar and potassium levels. If you have heart disease or are diabetic and notice a change in the results of your blood or urine sugar or potassium tests, check with your doctor.

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

umeclidinium and vilanterol Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Less common
  • Body aches or pain
  • chest pain
  • congestion
  • cough
  • dryness or soreness of the throat
  • fever
  • headache
  • hoarseness
  • pain or tenderness around the eyes and cheekbones
  • stuffy or runny nose
  • tender, swollen glands in the neck
  • tightness of the chest
  • trouble breathing
  • trouble swallowing
  • voice changes
Rare
  • Chest discomfort
  • dizziness
  • fainting
  • fast or irregular heartbeat
  • nausea
  • pain or discomfort in the arms, jaw, back, or neck
  • sweating
  • vomiting

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common
  • Diarrhea
  • difficulty having a bowel movement (stool)
  • muscle spasms
Rare
  • Acid or sour stomach
  • belching
  • burning, dry, or itching eyes
  • discharge or excessive tearing
  • dry mouth
  • heartburn
  • indigestion
  • lack or loss of strength
  • rash or itching skin
  • redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid
  • stomach discomfort, upset, or pain

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Side effects (in more detail)

The information contained in the Truven Health Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Truven Health products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Truven Health and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, TRUVEN HEALTH MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Truven Health does not assume any responsibility or risk for your use of the Truven Health products.

Copyright 2016 Truven Health Analytics, Inc. All Rights Reserved.

Hide